Cancer Journal

Papers
(The median citation count of Cancer Journal is 3. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-06-01 to 2026-06-01.)
ArticleCitations
PET Imaging of Metabolism, Perfusion, and Hypoxia29
Social Drivers of Cancer Risk and Outcomes Among African American Men29
Oncology Physician Workforce Diversity25
Toxicities From Antibody-Drug Conjugates24
HER2 and HER3 as Therapeutic Targets in Head and Neck Cancer23
Building a Bridge to Equity in Health and Health Care in Cancer Care22
Health Care Policy and Disparities in Health21
Stereotactic Body Radiation Therapy20
Melanoma—Modern Treatment for Metastatic Melanoma19
Therapeutic Targeting of FGFR Signaling in Head and Neck Cancer18
Evaluation of the Prognostic Role of Liver Metastases on Patient Outcomes18
Nonoperative Management for Rectal Cancer17
c-Met Signaling as a Therapeutic Target in Head and Neck Cancer16
Primary Prevention of Cancer15
Antibody Drug Conjugates in Multiple Myeloma14
Prostate Cancer, Race, and Health Disparity13
Germline Predisposition to Myelodysplastic Syndromes13
Metastatic Melanoma Treatment in Special Populations13
Diversity in Cancer Care13
Tumor-Infiltrating Lymphocyte and Other Cell Therapies for Metastatic Melanoma12
Rectal Cancer—The Only Constant Is Change12
Aurora Kinases as Therapeutic Targets in Head and Neck Cancer12
Advances in Stereotactic Body Radiation Therapy for Lung Cancer11
Hematopoietic Stem Cell Transplantation for Myelodysplastic Syndromes11
Current State of Neoadjuvant Therapy for Locally Advanced Rectal Cancer11
Overlooked and Damaging Impact of Structural Racism and Implicit Bias on US Health Care11
New Metabolomic Insights Into Cancer10
Overview of the Management of Higher-Risk Myelodysplastic Syndromes10
Supportive Care for Patients With Myelodysplastic Syndromes10
Updates in the Management of Uveal Melanoma10
Effective Personalization of Stereotactic Radiosurgery for Brain Metastases in the Modern Era10
Introduction9
Short- and Long-term Repercussions of Vancomycin on Immune Surveillance and the Efficacy of Antitumor Treatments8
Impact of Precision Medicine in Oncology8
Telehealth and Technology8
The Current Role of Human Papillomavirus Circulating Tumor DNA in Oropharynx Cancer7
PI3K Inhibition for Squamous Cell Head and Neck Carcinoma7
Discovery of Natural Products for Cancer Prevention7
A General Approach to Patients Presenting With Locally Advanced or Distant Metastatic Disease7
Evolving Landscape of Antibody Drug Conjugates in Lymphoma7
Role of the Microbiome in Immunotherapy of Melanoma7
How Far We’ve Come7
Telemedicine and cancer care: Barriers and strategies to optimize delivery: Erratum7
Spectrum From Clonal Hematopoiesis to Myelodysplastic Neoplasm/Syndromes and Other Myeloid Neoplasms7
What to Eat for Cancer Prevention6
Current State of Cell Therapies for Genitourinary Malignancies6
Molecular Imaging of Steroid Receptors in Breast Cancer6
Survival of the Fittest6
Telemedicine and Cancer Care6
What Role Does Radiotherapy Play in the Molecular Era for Intrahepatic Cholangiocarcinoma?6
Diagnostic and Therapeutic Application of Fibroblast Activation Protein Inhibitors in Oncologic and Nononcologic Diseases5
Repurposing Drugs for Cancer Prevention5
Impact of Precision Medicine in Oncology5
Severe Lymphopenia Predicts Poorer Survival in Patients With Rectal Cancer Undergoing Neoadjuvant Chemoradiation5
Updates in Classification of Myelodysplastic Syndrome5
The Gut Microbiome and Pancreatic Cancer Development and Treatment5
The Lung Microbiome in Carcinogenesis and Immunotherapy Treatment5
The Microbiome and Its Impact on Allogeneic Hematopoietic Cell Transplantation5
Antibody-Drug Conjugates in Myeloid Leukemias5
Recent Advances in Blood-Based Liquid Biopsy Approaches in Prostate Cancer5
STING Agonists in Head and Neck Squamous Cell Carcinoma5
Gene Expression Profiles in Cancers and Their Therapeutic Implications5
Local Excision for Early-Stage Rectal Adenocarcinomas5
Chimeric Antigen Receptor T-Cell Therapy4
Radiopharmaceuticals for Cancer Diagnosis and Therapy4
Digital Health for Oncological Care4
Nuclear Medicine Cancer Care—Current Status and Future Directions for Radiopharmaceutical Diagnostics and Theranostics for Cancer4
Epidemiology and Pathogenesis of Myelodysplastic Syndrome4
Evolution of Response-Based Radiotherapy for Hepatocellular Cancer4
Advancements in Understanding and Preventing Obesity-Related Colon Cancer4
The Management of Low-Risk Myelodysplastic Syndromes—Current Standards and Recent Advances4
Telemedicine and Burnout—How Enhancing Operational Support Can Improve Digital Health Tools4
Adoptive Cell Therapy for Advanced Solid Tumors4
Management of Low-Grade Gliomas4
The Utility of Interim Positron Emission Tomography Imaging to Inform Adaptive Radiotherapy for Head and Neck Squamous Cell Carcinoma4
Antibody-Drug Conjugates and Tissue-Agnostic Drug Development4
Preclinical In Vitro and In Vivo Models for Adoptive Cell Therapy of Cancer3
Targets for Cancer Prevention: Evolving Methodologies in Basic and Epidemiological Sciences Identify Interrelated Pathways and the Need for Holistic Approaches3
Shifting the Landscape of Spine and Non-Spine Bone Metastases3
Neoantigen-Specific T Cells in Adoptive Cell Therapy3
The Role of Circulating Tumor DNA for Management of Patients With Rectal Cancer3
Treatment of Stage III Resectable Melanoma—Adjuvant and Neoadjuvant Approaches3
Fecal Microbiota Transplantation as a Cancer Therapeutic3
Diversity and Disparities in Lung Cancer Outcomes Among Minorities3
0.046493053436279